Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.1105 per EA under NDC 42543078706. Its NADAC has been published 255 times since Aug 11, 2021.
Strength
7.5 mg/1
Manufacturer
Strides Pharma Inc.NDC
42543078706
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202330On Market Since
4/1/2021
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 255 times since Aug 11, 2021, and over the history we have for it it has declined 58.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1105 per EA |
|---|---|
| All-time high | $0.2683 (Aug 11, 2021) |
| All-time low | $0.0797 (Nov 20, 2024) |
| 52-week high | $0.1225 |
| 52-week low | $0.1105 |
| Median price | $0.1404 |
| Average price | $0.1508 |
| Largest weekly change | -42.2% (Nov 20, 2024) |
| Weeks tracked | 255 |
| Tracking since | Aug 11, 2021 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Strides Pharma Inc., is $0.1105 per EA (NDC 42543078706), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 58.8%. It has been tracked across 255 weekly CMS publications since Aug 11, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Aug 11, 2021, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.0797 (Nov 20, 2024) to a high of $0.2683 (Aug 11, 2021), with a median of $0.1404 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUSPIRONE HCL 7.5 MG TABLET, is $0.1039 per EA — about 6% below BUSPIRONE HCL 7.5 MG TABLET.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 42543078706) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification